Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
lebrikizumab
Pharma
Lilly secures FDA nod for atopic dermatitis therapy Ebglyss
Three years after starting an immunology unit, Lilly has gained its third FDA approval in the specialty area with a nod for Ebglyss to treat eczema.
Kevin Dunleavy
Sep 16, 2024 11:16am
Lilly suffers another FDA snub, this time for lebrikizumab
Oct 2, 2023 11:06am
Almirall turns to fine art to debunk atopic dermatitis myths
Sep 14, 2023 12:04pm
Eli Lilly is making a gung-ho push into immunology
May 19, 2022 10:14am
